Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

SAMI acquires AEC

Saudi Arabian Military Industries (SAMI) has announced the signing of a Term Sheet Agreement to acquire 100% ownership in Advanced Electronics Company (AEC), which took place at a Saudi Arabia/UK industry event in London in the

Towering problem cut down to size

A new training course in Kuwait aims to help provide local air traffic controllers with the skills to take up positions in the nation’s control towers. Alan Dron reports.

Airways New Zealand and DGCA Lebanon open advanced ATC simulation facility

Airways New Zealand and the Directorate General of Civil Aviation (DGCA) Lebanon have officially opened an advanced air traffic control (ATC) simulation facility – future-proofing ATC training in Lebanon for decades to come.

Etihad Airways to launch seasonal summer flights to Alexandria

Etihad Airways will launch seasonal summer flights from Abu Dhabi to Alexandria.

IATA: Data, digital transformation to drive future customer experience

The International Air Transport Association (IATA) has urged aviation stakeholders to embrace data and digital transformation to help deliver a frictionless customer experience while enhancing safety and efficiency.

Gulf Air adds Maldives as it welcomes its third Airbus 320neo

Gulf Air has welcomed the airline’s third Airbus A320neo, which on October 26 will begin operating to Gulf Air’s newest destination – Male in the Maldives.

ACCA19_SK0201080919
See us at
DIAC19_BT264161119ACCA19_BT_2404091019Dubai AS BT2006211119MEBAA BT2006260919